KLAS: 20% of community hospitals plan to change EMRs

Twenty percent of community hospitals plan to switch their EMR system during the next couple of years, according to a report from KLAS.

The Orem, Utah-based market researcher interviewed 500 healthcare professionals in community hospital settings about their experience with various EMR systems for the report, "Community Hospital EMRs Maturing for Meaningful Use." Eighty percent of respondents were confident that they could achieve meaningful use requirements with their current EMRs, even in hospitals where EMR adoption wasn't widespread.

"McKesson and Meditech C/S clients are most confident that their vendors will get them to Stage 1 of meaningful use by 2013," KLAS stated. "Meditech customers attribute this confidence to their systems' reliability and robust clinical capabilities, while McKesson customers cited solid partnerships and rapid delivery of new technology, especially CPOE."

However, KLAS also noted that 20 percent of those surveyed plan to switch EMR vendors in the next two years. Although non-meaningful use-certified products appear to be most at risk of abandonment, providers appear to doubt some certified products as well.

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.